Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Spinal Fusion Devices Market - Insights
Spinal fusion devices are used to provide stability to spinal structure, which has lost stability due to a fracture, degenerative disorders of the spine, trauma, tumors, and deformity. Spinal cord injuries majorly happen due to various reasons such as a blocked blood supply, infections, injuries, and compression by a fractured bone or a tumor. Spinal fusion devices technology and mechanism of functioning has evolved over the years. Advanced plating systems offer improved stability and structural integrity. Spinal fusion devices have innovative locking mechanisms and screw systems, which can have self-drilling and self-tapping functions, made from modern manufacturing material such as titanium alloy, and single as well as double holes per vertebrae through which the screw fixation is done.
Rapid product launch and frequent approval of novel spinal fusion devices are expected to drive growth of the global spinal fusion market
In 2015, Aesculap Implant Systems, a division of B. BRAUN MELSUNGEN AG, launched Modulift Vertebral Body Replacement System (VBR). It is the latest generation of expandable cage technology. In 2017, Stryker’s Spine division launched Serrato pedicle screw, a unique dual-lead screw intended for use in the non-cervical spine. In 2016, Stryker launched Aero-C Cervical Stability System at the meeting of the American Academy of Orthopedic Surgeons in Orlando. Entry of these novel products in market is expected to support the growth of global spinal fusion devices market in near future. Furthermore, frequent approvals of innovative products is also expected to drive market growth. For instance in 2018, Orthofix International N.V., received U S Food and Drug Administration 510(k) clearance of FORZA XP Expandable Spacer System. FORZA XP is designed to restore normal disc height in patients suffering from degenerative disc disease. In 2016, Orthofix International N.V. received US Food and Drug Administration 510(k) clearance for FORZA PTC (Peek Titanium Composite) Spacer System, and Wenzel Spine, Inc., received clearance from the U.S. Food and Drug Administration (FDA) to market VariLift-LX, an interbody fusion device for stand-alone use in the lumbar spine.
The global spinal fusion devices market was valued at US$ 7,462.4 million in 2016 and is expected to witness a CAGR of 4.6% over the forecast period (2017 – 2025).
Figure 1. Global Spinal Fusion Devices Market Share (%), By Region, 2017 – 2025
Source: Coherent Market Insights Analysis (2017)
Increasing prevalence of spinal deformities is expected to drive growth of the global spinal fusion device market
Factors responsible for spinal deformities include weight, diet, smoking, and other lifestyle factors. Early onset of degenerative spinal changes is attributed to the toxins in cigarette smoke damaging the cartilage of spine. According to World Health Organization (WHO), more than 1.1 billion people smoked tobacco in 2015 worldwide. According to a study published in SpineUniverse in 2017, disc herniation is the most common indication for spinal surgery, and around 75% of all spinal surgeries were performed for herniated disc. Increasing prevalence of spinal deformities due to unhealthy lifestyle and high chances of disc herniation are expected to drive growth of the spinal fusion devices market in near future.
Furthermore, key players in the spinal fusion devices market are focusing of strategic mergers and acquisitions to expand their product portfolio and to strengthen their position in new geographies. For instance in 2016, Zimmer acquired LDR Holding Corporation to enhance innovation and growth of their spine segment. In 2016, Globus Medical, Inc. acquired the international operations and distribution channels of Alphatec Holdings, Inc. This acquisition has expanded company's product portfolio and provided an immediate access to Japan and increased presence and penetration in other geographical areas, though the Alphatec's extensive international distributer to increase its international sales.
Key players operating in global spinal fusion devices market include Zimmer Biomet Holdings, Inc., Inc., Stryker Corporation, Inc., Exactech, Inc., Orthofix International N.V., Globus Medical, Inc., NuVasive, Inc., Medtronic Plc., Depuy Synthes, B. Braun Melsungen AG, Wenzel Spine, Inc., K2M Group Holdings, Inc., Centinel Spine, Inc., and Spineart Geneva SA.